Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3,4-DAP in Brugada Syndrome
NCT00701077Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amifampridine in Brugada syndrome, sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2008; status: terminated.
02
Drugs
amifampridine
03
Conditions
Brugada syndrome
Beyond the preview
Go deeper on NCT00701077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701077.